Metraipolis › archive › dc_5ee98915ec94
Sex and risk of hyperprogressive disease in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis — Europe PMC PMID:42819259
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42819259
- DOI
- 10.3389/fimmu.2026.1860831
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T14:54:10.561Z
- SHA-256 of the archived text
7e384fd3dbf9b2a4a6f84e6a77fa33f51064bc5d1ceba2b039c58822ff7903e0- Stable URL of this page
https://metraipolis.com/documento/dc_5ee98915ec94
How to cite
Sex and risk of hyperprogressive disease in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis — Europe PMC PMID:42819259 — Europe PMC (en), https://europepmc.org/article/MED/42819259 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ee98915ec94 (Metraipolis archive dc_5ee98915ec94, sha256 7e384fd3dbf9b2a4a6f84e6a77fa33f51064bc5d1ceba2b039c58822ff7903e0)
BibTeX
@misc{dc5ee98915ec94,
title = {Sex and risk of hyperprogressive disease in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis — Europe PMC PMID:42819259},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42819259},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ee98915ec94; sha256 7e384fd3dbf9b2a4a6f84e6a77fa33f51064bc5d1ceba2b039c58822ff7903e0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42819259. Agents can read the archived copy with the MCP tool read_document.